986
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Circular RNA hsa_circ_0077837 is upregulated in non-small cell lung cancer to downregulate phosphatase and tensin homolog through methylation

, , , , , & ORCID Icon show all
Pages 6711-6718 | Received 15 Nov 2021, Accepted 31 Dec 2021, Published online: 04 Mar 2022

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Team NLSTR. Lung cancer incidence and mortality with extended follow-up in the national lung screening trial. J Thorac Oncol. 2019;14(10):1732–1742.
  • Barta JA, Powell CA, and Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1):8.
  • Perloff T, King JC, Rigney M, et al. Survivor guilt: the secret burden of lung cancer survivorship. J Psychosoc Oncol. 2019;37(5):573–585.
  • Reddy KP, Kong CY, Hyle EP, et al. Lung cancer mortality associated with smoking and smoking cessation among people living with HIV in the United States. JAMA Intern Med. 2017;177(11):1613–1621.
  • Pirie K, Peto R, Green J, et al. Lung cancer in never smokers in the UK million women study. Int J Cancer. 2016;139(2):347–354.
  • Oser MG, Niederst MJ, Sequist LV, et al. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015;16(4):e165–72.
  • Vijayvergia N, Shah PC, Denlinger CS. Survivorship in non-small cell lung cancer: challenges faced and steps forward. J Natl Compr Canc Netw. 2015;13(9):1151–1161.
  • Cheng L, Alexander RE, Maclennan GT, et al. Molecular pathology of lung cancer: key to personalized medicine. Mod Pathol. 2012;25(3):347–369.
  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
  • Mayekar MK, Bivona TG. Current landscape of targeted therapy in lung cancer. Clin Pharmacol Ther. 2017;102(5):757–764.
  • Noor ZS, Cummings AL, Johnson MM, et al. Targeted therapy for non-small cell lung cancer. Semin Respir Crit Care Med. 2020;41(3):409–434.
  • Di X, Jin X, Li R, et al. CircRNAs and lung cancer: biomarkers and master regulators. Life Sci. 2019;220:177–185.
  • Sheng WZ, Dong TG, and Zhang B, et al. Novel circular RNA hsa_circ_0077837 suppresses colorectal cancer cell proliferation by regulating the microRNA 21/phosphatase and tensin homolog axis. 2020. doi:10.21203/rs.2.19904/v1.
  • Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4(1):127–150.
  • Gainor JF, Tan DS, De Pas T, et al. Progression-free and overall survival in ALK-positive NSCLC patients treated with sequential crizotinib and ceritinib. Clin Cancer Res. 2015;21(12):2745–2752.
  • Chen N, Zhao G, Yan X, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19(1):218.
  • Zhang Y, Zeng S, Wang T. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs. Bioengineered. 2021. DOI:10.1080/21655979.2021.1999370
  • Hu X, Wang P, Qu C, et al. Circular RNA Circ_0000677 promotes cell proliferation by regulating microRNA-106b-5p/CCND1 in non-small cell lung cancer. Bioengineered. 2021;12(1):6229–6239.
  • Zhang CC, Li Y, Feng XZ, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12(1):414–425.